Aisling Capital portfolio

Aisling Capital (Venture capital) is known to hold 118 companies, 22 of them startups. 27 of them are hiring now, with 3,178 open roles. Its companies closed 3 venture rounds in 12 months, raising -. Most of them work in Prescription Drugs, Biologics & Biosimilars, Oncology Therapeutics.

Source: Alion Venture capital Oct 25, 2026
Investments
118
22 of them startups
Hiring now
27
3,178 open roles
Rounds in 12 months
3
Exits
35

Companies Aisling Capital has invested in

GSK plc Vaccines · United Kingdom Venture round · this month portfolio pageSep 25
Compass Pathways Prescription Drugs · United Kingdom Venture round · 1 mo ago 142 roles portfolio pageSep 25
F2G. United Kingdom Venture round · 10 mo ago portfolio pageSep 25
Spruce Biosciences Venture round $50M · 12 mo ago portfolio pageSep 25
Wugen Cell & Gene Therapy Venture round $123.3M · 14 mo ago portfolio pageSep 25
Treeline Biosciences Drug Discovery · United States Venture round $200.1M · 14 mo ago 9 roles portfolio pageSep 25
Earlens Health & Medical Electronics · United States Venture round $8M · 20 mo ago portfolio pageSep 25
avrobio.com Venture round $185M · 20 mo ago portfolio pageSep 25
Marker Therapeutics United States Venture round $16.1M · 22 mo ago portfolio pageSep 25
Menlo Therapeutics Venture round $88.2M · 2 yr ago portfolio pageSep 25
Lensar Venture round $20M · 3 yr ago portfolio pageSep 25
CalciMedica Biologics & Biosimilars · United States Venture round $10.3M · 3 yr ago portfolio pageSep 25
Dren Bio United States Venture round $62.5M · 4 yr ago portfolio pageSep 25
Antios Therapeutics United States Series B $75M · 4 yr ago portfolio pageSep 25
Merck.com Prescription Drugs · United States Venture round $486 · 5 yr ago 3 roles portfolio pageSep 25
Mindful Health Solutions Psychiatric Care Venture round · 5 yr ago 2 roles portfolio pageSep 25
Forge Biologics CRO & CDMO Services · United States Series B $120M · 5 yr ago 13 roles portfolio pageSep 25
Biomea Fusion United States Venture round $56M · 5 yr ago portfolio pageSep 25
elevationoncology.com Venture round $65M · 5 yr ago portfolio pageSep 25
Verona Pharma Venture round $200.2M · 6 yr ago portfolio pageSep 25
Colorescience Skincare · United States Venture round $3M · 6 yr ago portfolio pageSep 25
Jazz Pharmaceuticals Iberia S.L. United States Venture round $34.9M · 7 yr ago portfolio pageSep 25
NUVATION BIO Oncology Therapeutics · United States Venture round $275.3M · 7 yr ago 1 role portfolio pageSep 25
Catalent APIs & Drug Manufacturing · United States Venture round $650M · 7 yr ago portfolio pageSep 25
Agile Therapeutics ® United States Venture round $7.8M · 7 yr ago portfolio pageSep 25
Dermira Venture round $1M · 7 yr ago portfolio pageSep 25
Atreca Venture round $125M · 8 yr ago portfolio pageSep 25
Ajax Health United States Venture round $125M · 8 yr ago portfolio pageSep 25
Pelle Pharm Venture round $7.5M · 8 yr ago portfolio pageSep 25
Litestrategy Venture round $75M · 8 yr ago portfolio pageSep 25
Prolacta United States Venture round $8.9M · 8 yr ago portfolio pageSep 25
Asensus Surgical Surgical Instruments & Devices · United States Convertible Note $950k · 9 yr ago portfolio pageSep 25
Sanofi Prescription Drugs Venture round $28.5M · 9 yr ago portfolio pageSep 25
Viewray Venture round $26.1M · 9 yr ago portfolio pageSep 25
t2biosystems.com Venture round $39.7M · 10 yr ago portfolio pageSep 25
Zosanopharma Venture round $7.5M · 10 yr ago portfolio pageSep 25
Johnson & Johnson Prescription Drugs · United States 1095 roles portfolio pageSep 25
Merck & Co. Prescription Drugs · United States 782 roles portfolio pageSep 25
Pfizer Prescription Drugs · United States 335 roles portfolio pageSep 25
Galderma Dermatology · Switzerland 249 roles portfolio pageSep 25
Gilead Sciences Prescription Drugs · United States 244 roles portfolio pageSep 25
Bausch Health Prescription Drugs · Canada 75 roles portfolio pageSep 25
Genentech Biologics & Biosimilars 139 roles portfolio pageSep 25
Scholar Rock Biologics & Biosimilars · United States 32 roles portfolio pageSep 25
Paratek Pharmaceuticals Infectious Disease Therapeutics · United States 31 roles portfolio pageSep 25
Ascendis Pharma Prescription Drugs · Denmark 30 roles portfolio pageSep 25
Reckitt FMCG & Consumer Brand Groups · United Kingdom 16 roles portfolio pageSep 25
GondolaBio Rare Disease Therapeutics · United States 13 roles portfolio pageSep 25
Syndax Oncology Therapeutics · United States 8 roles portfolio pageSep 25
Bicara Therapeutics Biologics & Biosimilars 7 roles portfolio pageSep 25
Harmony Biosciences Biologics & Biosimilars · United States 3 roles portfolio pageSep 25
Arcus Biosciences Prescription Drugs 2 roles portfolio pageSep 25
Kurosbio Orthopedic & Spine Implants 2 roles portfolio pageSep 25
Spyre Therapeutics Immunology & Inflammation Therapeutics 1 role portfolio pageSep 25
90Phutzac Sports Media portfolio pageSep 25
ADMA Biologics, Inc. Biologics & Biosimilars portfolio pageSep 25
Advion Laboratory Equipment · United States portfolio pageSep 25
Alfasigmausa Prescription Drugs portfolio pageSep 25
Ambit Biosciences Inc. Biologics & Biosimilars portfolio pageSep 25
Archimica APIs & Drug Manufacturing portfolio pageSep 25
Biohaven Biologics & Biosimilars portfolio pageSep 25
Cynapsus Therapeutics Inc. Prescription Drugs · Canada portfolio pageSep 25
Medtronic window Fitness · United States portfolio pageSep 25
12

Focus

Markets
Prescription Drugs11%
Biologics & Biosimilars8%
Oncology Therapeutics7%
Drug Discovery4%
Infectious Disease Therapeutics3%
Surgical Instruments & Devices3%
APIs & Drug Manufacturing3%
Rare Disease Therapeutics3%
Where its companies are
United States25%
United Kingdom3%
Canada2%
Denmark1%
Switzerland1%
Stage of its companies
Venture, series not stated94%
Series B6%

Questions about Aisling Capital

How many companies has Aisling Capital invested in?

Aisling Capital is known to hold 118 companies: 22 startups, and 35 exits so far, read from its own portfolio page and the funding rounds that name it.

Is Aisling Capital investing now?

Aisling Capital has no round in the press in 12 months and no new company on its portfolio page in 90 days.

What does Aisling Capital invest in?

The markets of the companies Aisling Capital holds: Prescription Drugs (11%), Biologics & Biosimilars (8%), Oncology Therapeutics (7%), Drug Discovery (4%), Infectious Disease Therapeutics (3%).

Which Aisling Capital portfolio companies are hiring?

27 companies Aisling Capital holds are hiring now, with 3,178 open roles listed on this page.

Who does Aisling Capital invest alongside?

The investors that hold the most companies together with Aisling Capital: NEA, RA Capital Management, EcoR1 Capital, Foresite Capital, Sofinnova Investments.

How this page is made

A company counts as a holding when the investor’s own portfolio page links to it, a program’s catalog lists it, or a funding round in the press names the investor. The numbers are rebuilt every night; each company shows where it came from and when it was first seen.

Sources: its portfolio page, read Oct 25

Aisling Capital portfolio: 118 known companies. Alion, Oct 25, 2026. https://alion.io/company/aisling-capital/portfolio

Licence: CC BY-SA 4.0JSON